Loading...
Lifecore Biomedical, Inc.
LFCR•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$7.33
$-0.10(-1.35%)
Lifecore Biomedical, Inc. (LFCR) Financial Performance & Income Statement Overview
Review Lifecore Biomedical, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
24.20%
↑ 24.20%
Operating Income Growth
135.77%
↑ 135.77%
Net Income Growth
111.76%
↑ 111.76%
Operating Cash Flow Growth
99.37%
↑ 99.37%
Operating Margin
-15.11%
↓ 15.11%
Gross Margin
33.45%
↑ 33.45%
Net Profit Margin
-34.27%
↓ 34.27%
ROE
-264.05%
↓ 264.05%
ROIC
-9.53%
↓ 9.53%
Lifecore Biomedical, Inc. (LFCR) Income Statement & Financial Overview
Review Lifecore Biomedical, Inc.'s (LFCR) income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $32.56M | $24.70M | $37.89M | $35.70M |
| Cost of Revenue | $21.48M | $19.32M | $20.61M | $23.81M |
| Gross Profit | $11.08M | $5.39M | $17.27M | $11.89M |
| Gross Profit Ratio | $0.34 | $0.22 | $0.46 | $0.33 |
| R&D Expenses | $1.92M | $2.19M | $2.16M | $2.17M |
| SG&A Expenses | $11.12M | $14.30M | $12.22M | $9.85M |
| Operating Expenses | $13.04M | $16.97M | $14.38M | $12.02M |
| Total Costs & Expenses | $34.52M | $36.29M | $35.00M | $35.83M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $5.46M | $5.37M | $5.79M | $4.29M |
| Depreciation & Amortization | $2.04M | $1.99M | $1.39M | $4.44M |
| EBITDA | $489000.00 | -$8.89M | $4.64M | $2.11M |
| EBITDA Ratio | $0.02 | -$0.36 | $0.12 | $0.06 |
| Operating Income | -$1.96M | -$11.58M | $2.89M | -$124000.00 |
| Operating Income Ratio | -$0.06 | -$0.47 | $0.08 | -$0.003 |
| Other Income/Expenses (Net) | -$4.57M | -$4.67M | -$9.29M | $217000.00 |
| Income Before Tax | -$6.53M | -$16.25M | -$7.14M | $15.002M |
| Income Before Tax Ratio | -$0.20 | -$0.66 | -$0.19 | $0.42 |
| Income Tax Expense | $43000.00 | -$25000.00 | -$57000.00 | $217000.00 |
| Net Income | -$6.57M | -$16.23M | -$7.08M | $15.63M |
| Net Income Ratio | -$0.20 | -$0.66 | -$0.19 | $0.44 |
| EPS | -$0.25 | -$0.53 | -$0.23 | $0.51 |
| Diluted EPS | -$0.25 | -$0.53 | -$0.23 | $0.43 |
| Weighted Avg Shares Outstanding | $34.36M | $30.86M | $30.56M | $30.49M |
| Weighted Avg Shares Outstanding (Diluted) | $34.36M | $30.86M | $30.56M | $36.61M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan